Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Car makers go on trial in UK over diesel testing claims

(Sharecast News) - Legal action against some of the world's biggest car makers got underway in London on Monday, over claims they cheated on diesel emissions tests. The mass lawsuit - which has nearly 850,000 claimants - has been brought by owners of diesel vehicles made by Mercedes-Benz, Ford, Nissan, Renault and Stellantis-owned Peugeot-Citroen.

It alleges that the companies used so-called defeat devices, which are unlawful, when testing emissions.

The High Court hearing will focus on a small sample of diesel vehicles produced by the five manufacturers, to see if they used any prohibited devices. A judgement is not expected until next summer, while any potential damages would then be decided at a further trial.

The manufacturers deny the claims, however, arguing that they are "fundamentally flawed", according to Reuters.

They have also rejected any similarity with a scandal that engulfed Volkswagen in 2015.

The German car maker was hit when widespread fines and lawsuits after it was found to have cheated emissions tests.

In 2022, it agreed to pay £193m to more than 90,000 drivers in England and Wales, and has now paid out more than €32bn over the scandal to date.

Mercedes told the BBC that the mechanisms used in its tests were "justifiable from a technical and legal standpoint", while Renault and Stellantis reiterated that the vehicles they sold were compliant with regulation at the times.

Ford said the claims had no merit, while Nissan reaffirmed its commitment to compliance across all its markets.

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.